Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update

Novozymes A/S (OTCMKTS:NVZMY) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 270,706 shares, a growth of 66,741.0% from the March 15th total of 405 shares. Based on an average trading volume of 359,621 shares, the short-interest ratio is presently 0.8 days. Approximately 0.1% of the shares of the stock are short sold.

Novozymes A/S Stock Up 0.1%

OTCMKTS:NVZMY opened at $60.04 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.44 and a current ratio of 0.72. The company has a market cap of $24.89 billion, a PE ratio of 42.89, a PEG ratio of 1.11 and a beta of 1.06. Novozymes A/S has a 52-week low of $49.90 and a 52-week high of $75.99. The stock has a 50-day simple moving average of $58.62 and a 200 day simple moving average of $61.27.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.22 billion. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.37%. On average, sell-side analysts expect that Novozymes A/S will post 1.82 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Rothschild & Co Redburn upgraded Novozymes A/S to a “strong-buy” rating in a report on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy”.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).